Advertisement

Quality of Life Benefit from Avoiding Allogeneic Blood Transfusion

  • R. F. Nease
  • T. W. Croghan
  • B. Littenberg
Conference paper
  • 90 Downloads
Part of the Yearbook of Intensive Care and Emergency Medicine book series (YEARBOOK, volume 1997)

Abstract

Allogeneic blood transfusions (ABT) are frequent, and they impose several risks, including hepatitis B and C infection, human immunodeficiency virus (HIV) infection, HTLV I/II infection, and post-transfusion reaction [1–13]. Although little is known about patient concerns regarding ABT, the rapid growth in strategies for autologous blood donation suggests a substantial aversion toward these risks [14].

Keywords

Human Immunodeficiency Virus Utility Function Human Immunodeficiency Virus Infection Chronic Active Hepatitis Standard Gamble 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Linden JV (1991) The risk of ABO-incsompatible mistransfusion. A report of 104 transfusion errors. Transfusion 31: 475–480Google Scholar
  2. 2.
    Sazama K (1990) Reports of 355 transfusion-associated deaths. 1976 through 1985. Transfusion 30: 583–590PubMedCrossRefGoogle Scholar
  3. 3.
    Donahue JG, Munoz A, Ness PM, et al (1992) The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 327: 369–373PubMedCrossRefGoogle Scholar
  4. 4.
    Cohen ND, Munoz A, Reitz BA, et al (1989) Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery. N Engl J Med 320: 1172–1176PubMedCrossRefGoogle Scholar
  5. 5.
    Contreras M, Barbara JAJ, Anderson CC, et al (1991) Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis. Lancet 337: 753–757PubMedCrossRefGoogle Scholar
  6. 6.
    Cumming PD, Wallace EL, Schorr JB, Dodd RY (1989) Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody negative. N Engl J Med 321: 941–946PubMedCrossRefGoogle Scholar
  7. 7.
    Dodd R (1990) Will blood products be free of infectious agents? In: Nance SJ (ed) Transfusion Medicine in the 1990s. American Association of Blood Banks. Arlington, VA, pp 223–251Google Scholar
  8. 8.
    Brecher ME, Taswell HF (1991) Hemolytic transfusion reactions. In: Rossi EC, Moss GS (eds) Principles of transfusion medicine. Williams Wilkins, Baltimore, MD, pp 619–634Google Scholar
  9. 9.
    Alter HJ (1991) Transfusion-transmitted non-A, non-B hepatitis. In: Rossi EC, Moss GS (eds) Principles of transfusion medicine. Williams Wilkins, Baltimore, MD, pp 573–582Google Scholar
  10. 10.
    Greenberger PA (1991) Plasma anaphylaxis and immediate type reactions. In: Rossi EC, Moss GS (eds) Principles of transfusion medicine. Williams Wilkins, Baltimore, MD, pp 635–640Google Scholar
  11. 11.
    Van Der Poel CL, Reesink HW, Schassbert W, et al (1990) Infectivity of blood seropositive for hepatitis C antibodies. Lancet 335: 558–560PubMedCrossRefGoogle Scholar
  12. 12.
    Seef LB, Dienstag JL (1991) Transfusion-transmitted hepatitis A, B, and D. In: Rossi EC, Moss GS (eds) Principles of transfusion medicine. Williams Wilkins, Baltimore, MD, pp 561–573Google Scholar
  13. 13.
    Zuck TF (1991) Transfusion-transmitted human retroviruses. In: Rossi EC, Moss GS (eds) Principles of transfusion medicine. Williams Wilkins, Baltimore, MD, pp 583–596Google Scholar
  14. 14.
    Surgenor DM, Wallace EL, Hao SHS, Chapman RH (1990) Collection and transfusion of blood in the United States, 1982–1988. N Engl J Med 322: 1646–1651PubMedCrossRefGoogle Scholar
  15. 15.
    Sox H, Blatt M, Higgins M, Marton K (1988) Medical decision-making. Butterworths, BostonGoogle Scholar
  16. 16.
    Weinstein M, Fineberg H (1980) Clinical decision analysis. Saunders, PhiladelphiaGoogle Scholar
  17. 17.
    Furlong W, Feeny D, Torrance GW, Barr R, Horsman J (1990) Guide to design and development of health-state utility instrumentation. Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, Ontario, CanadaGoogle Scholar
  18. 18.
    Eraker SA, Sox HC Jr (1981) Assessment of patients’ preferences for therapeutic outcomes. Med Decis Making 1: 29–39PubMedCrossRefGoogle Scholar
  19. 19.
    Kahnemann D, Tversky A (1982) The psychology of preferences. Sci Am J: 160–173Google Scholar
  20. 20.
    McNeil BJ, Pauker SG, Sox HC Jr, Tversky A (1982) On the elicitation of preferences for alternative therapies. N Engl J Med 306: 1259–1262PubMedCrossRefGoogle Scholar
  21. 21.
    Tversky A, Kahneman D (1981) The framing of decisions and the psychology of choice. Science 211: 453–458PubMedCrossRefGoogle Scholar
  22. 22.
    Sumner W, Nease R, Littenberg B, Kneeland T, O’Connor G (1991) U-titer: A utility assessment tool. Med Decis Making 11: 327–330Google Scholar
  23. 23.
    Sumner W, Nease R, Littenberg B (1991) U-titer: A utility assessment tool. Fifteenth Annual Symposium on Computer Applications in Medical Care. Washington, D.C., pp 710–715Google Scholar
  24. 24.
    Nease RF Jr, Kneeland T, O’Connor G, et al (1995) Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. JAMA 273: 1185–1190PubMedCrossRefGoogle Scholar
  25. 25.
    Zug K, Littenberg B, Baughman R, et al (1995) Assessing the preferences of patients with psoriasis. A quantiative, utility approach. Arch Dermatol 131: 561–568PubMedCrossRefGoogle Scholar
  26. 26.
    Alexander NE, Ross J, Sumner W, Nease RF, Littenberg B (1995) The effect of an educational intervention on the perceived risk of breast cancer. J Gen Intern Med 11: 92–97CrossRefGoogle Scholar
  27. 27.
    Nease R, Birkmeyer J, Wong J, et al (1994) Tailoring practice guidelines to the individual. The importance of patient-specific estimates of risk and benefit in elective coronary artery bypass graft surgery. Circulation 90: I-91 (Abst)Google Scholar
  28. 28.
    Nease RF Jr, Owens DK (1994) A method for estimating the cost-effectiveness of incoporating patient preferences into practice guidelines. Med Decis Making 14: 382–392PubMedCrossRefGoogle Scholar
  29. 29.
    Nease R, Hynes L, Littenberg B, Tosteson A, Sumner W, Owens D (1994) Variation in patient preferences for outcomes associated with the management of mild hypertension: Implications for practice guidelines. San Diego, CA, p 25 (Abst)Google Scholar
  30. 30.
    Sanders G, Owens D, Padian N, Cardinalli A, Sullivan A, Nease R (1994) A computer-based interview to identify HIV risk behaviors and to assess patient utilities for HIV-related health states. Hanley Belfus, Washington DC, pp 20–24Google Scholar
  31. 31.
    Gage B, Cardinalli A, Albers G, Owens D (1995) Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with non-valvular atrial fibrillation. JAMA 274: 1839–1845PubMedCrossRefGoogle Scholar
  32. 32.
    Amin AN, Nease RF Jr, Amin SS, Littenberg B (1997) Determinants of the cost-effectiveness of cataract extraction. Med Decis Making (In press) (Abst)Google Scholar
  33. 33.
    Nease RF Jr, Tsai R, Hynes LM, Littenberg B (1996) Automated utility assessment of global health. Quality of Life Research 5: 175–182PubMedCrossRefGoogle Scholar
  34. 34.
    Handler R, Hynes LM, Nease RF Jr (1997) Effect of locus of control and consideration of future consequences on time tradeoff utilities for current health. Quality of Life Research (In press)Google Scholar
  35. 35.
    Hynes L, Levine A, Littenberg B, Nease R (1994) Development and comparison of two utility-based measures of regret. Med Decis Making 14: 433 (Abst)Google Scholar
  36. 36.
    Owens D, Nease RF (1990) Physician beliefs about occupational risk and severity of health states associated with HIV and hepatitis infection. Sixth Annual International Conference on AIDS 3: 308 (Abst)Google Scholar
  37. 37.
    Owens D, Nease RF (1992) Occupational exposure to HIV and hepatitis B virus. A comparative analysis of risk. Am J Med 92: 503–512PubMedCrossRefGoogle Scholar
  38. 38.
    Longini IMJ, Clark WS, Byers RH (1989) Statistical analysis of the stages of HIV infection using a Markov model. Stat Med 8: 831–843PubMedCrossRefGoogle Scholar
  39. 39.
    Pliskin J, Shepard D, Weinstein M (1980) Utility functions for life years and health status. Operations Research 28: 206–224CrossRefGoogle Scholar
  40. 40.
    McNeil BJ, Weichselbaum R, Pauker SG (1978) Fallacy of the five-year survival in lung cancer. N Engl J Med 299: 1397–1401PubMedCrossRefGoogle Scholar
  41. 41.
    Verhoef LCG, de Haan AFJ, van Daal WAJ (1993) Risk attitude in gambles with years of life. Empirical support for prospect theory. Med Decis Making 14: 194–200CrossRefGoogle Scholar
  42. 42.
    Nease RF (1994) Risk attitudes on gambles involving length of life. Aspirations, variations and ruminations. Med Decis Making 14: 201–203PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • R. F. Nease
  • T. W. Croghan
  • B. Littenberg

There are no affiliations available

Personalised recommendations